Gastrointestinal Cancer News

CHICAGO — Proton chemoradiotherapy significantly reduced incidence of adverse events associated with unplanned hospitalizations compared with traditional photon chemoradiotherapy among adults with nonmetastatic cancers, according to results of a comparative effectiveness study presented at ASCO Annual Meeting.

An oral cryotherapy intervention that involved ice chips appeared to reduce oxaliplatin-induced oral symptoms among a cohort of patients with gastrointestinal cancer, according to study findings.

An increase in the number of immune checkpoint inhibitors approved by the FDA, along with more indications, means that 43% of patients with cancer in the United States are eligible to receive these drugs, according to an analysis published in JAMA Network Open.

Neoadjuvant FOLFIRINOX chemotherapy with losartan followed by chemoradiotherapy appeared associated with a high rate of margin-negative resection and improved survival among patients with locally advanced pancreatic ductal adenocarcinoma, according to results of a single-arm phase 2 study published in JAMA Oncology.

The use of statins appeared associated with lower all-cause and cancer-specific mortality among patients with colorectal cancer, according to results of a meta-analysis published in Cancer Medicine.

Fox Chase Cancer Center announced several faculty appointments and promotions.

Raja M. Flores, MD, received New York University’s Distinguished Alumni Service Award, which recognizes his accomplishments and services to the institution as both a student and alumnus.

SAN DIEGO — In this exclusive video from Digestive Disease Week, John B. Kisiel, MD, a gastroenterologist at the Mayo Clinic, discusses the results of two studies that involved stool-based testing for the detection of colon cancer.

SAN DIEGO — In this video from Digestive Disease Week, Shounak Majumder, MD, a gastroenterologist at the Mayo Clinic, discusses the results of a study that assessed the accuracy of a blood-based test for detecting pancreatic cancer.

A study underway in West Virginia is designed to evaluate a novel blood test that may prove a more acceptable alternative for patients unwilling to undergo a screening colonoscopy.